BridgeMD
New treatment option for Warts
Official title Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts
ClinicalTrials.gov ID: NCT07534865
What this study is testing
What is 3% hydrogen peroxide solution?
3% hydrogen peroxide solution is an investigational medicine, being studied as a potential treatment for warts.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Hyperthermia treatment (hyperthermia) refers to treating diseases with temperature (39-45 ° C) beyond normal body temperature,. It has been reported that local warming at 44 ° C is able to effectively mobilize the body's immunity and clear HPV infected lesions, such as condyloma acuminatum and verruca vulgaris, etc.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 65
You may be able to join if
- Age 6-65 years, male or female;
- Clinically diagnosed with common warts, palmar/plantar/digital warts (≥1 lesion), with a Physician's Wart Assessment score ≥2 (0: no visible wart, no...
- The subject or legal guardian is able to understand and sign the informed consent form and agrees to participate in the study.
You likely can't join if
- people presenting with atypical warts clinically;
- people with immune dysfunction or autoimmune diseases;
- Pregnant or breastfeeding women;
- people who have received human papillomavirus (HPV) vaccination within the past 6 months;
- people who have undergone the following systemic treatments within the specified time frames: immunomodulators/immunosuppressants (e.g., etanercept)...
- people who have received the following treatments on or around the warts within the specified time frames: laser or other photochemical therapies...
See the full eligibility criteria
- Age 6-65 years, male or female;
- Clinically diagnosed with common warts, palmar/plantar/digital warts (≥1 lesion), with a Physician's Wart Assessment score ≥2 (0: no visible wart, no further treatment required; 1: visible wart, diameter \<3 mm; 2...
- The subject or legal guardian is able to understand and sign the informed consent form and agrees to participate in the study.
- people presenting with atypical warts clinically;
- people with immune dysfunction or autoimmune diseases;
- Pregnant or breastfeeding women;
- people who have received human papillomavirus (HPV) vaccination within the past 6 months;
- people who have undergone the following systemic treatments within the specified time frames: immunomodulators/immunosuppressants (e.g., etanercept), within 4 months; corticosteroids (inhaled and intranasal use...
- people who have received the following treatments on or around the warts within the specified time frames: laser or other photochemical therapies (intense pulsed light, photodynamic therapy), within 3 months...
- people with a history of the following diseases prior to enrollment: skin malignancy within the past 6 months, premalignant skin conditions (actinic keratosis) within the past 6 months, or currently in the acute...
- people with diseases affecting skin healing, such as diabetes mellitus, vitamin A deficiency, etc.;
- people with cold-sensitive conditions such as cryoglobulinemia or cold urticaria that may lead to abnormal observation results;
- people with severe dysfunction of the heart, lung, liver, kidney, hematopoietic system, or other vital organs.
The study team makes the final eligibility decision.
Where it's taking place
- Shenyang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shenyang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.